{"nct_id":"NCT03624036","title":"Study to Evaluate the Safety and Tolerability of Brexucabtagene Autoleucel (KTE-X19) in People With Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma","status":"TERMINATED","status_verified_date":"2023-10","start_date":"2018-11-15","start_date_type":"ACTUAL","primary_completion_date":"2021-02-12","primary_completion_date_type":"ACTUAL","completion_date":"2022-11-18","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GILD"]}